Literature DB >> 17356008

Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats.

Kerry L Mullen1, Angela C Smith, Kathryn A Junkin, David J Dyck.   

Abstract

High-fat (HF) diets induce insulin resistance and alter lipid metabolism, although controversy exists regarding the impact of saturated vs. polyunsaturated fats. Adiponectin (Ad) stimulates fatty acid (FA) oxidation and improves insulin sensitivity in humans and rodents, due in part to the activation of AMP-activated protein kinase (AMPK) and subsequent deactivation of acetyl coenzyme A carboxylase (ACC). In genetically obese, diabetic mice, this acute stimulatory effect on AMPK in muscle is lost. The ability of a HF diet to induce skeletal muscle Ad resistance has not been examined. The purpose of this study was to determine whether Ad's effects on FA oxidation and AMPK/ACC would be reduced following different HF diets, and if this coincided with the development of impaired maximal insulin-stimulated glucose transport. Rats were fed a control (10% kcal fat, CON), high unsaturated fat (60% kcal safflower oil, SAFF), or high saturated fat diet (60% kcal lard, LARD) for 4 wk. Following the dietary intervention, glucose transport, lipid metabolism, and AMPK/ACC phosphorylation were measured in the presence and absence of globular Ad (gAd, 2.5 microg/ml) in isolated soleus muscle. LARD rats showed reduced rates of maximal insulin-stimulated glucose transport compared with CON and SAFF (+68 vs. +172 and +184%, P < or = 0.001). gAd increased pACC (+25%, P < or = 0.01) and FA oxidation (+28%, P < or = 0.05) in CON rats, but not in either HF group. Thus 4 wk of HF feeding results in the loss of gAd stimulatory effect on ACC phosphorylation and muscle FA oxidation, and this can occur independently of impaired maximal insulin-stimulated glucose transport.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356008     DOI: 10.1152/ajpendo.00545.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  28 in total

Review 1.  Systemic adiponectin malfunction as a risk factor for cardiovascular disease.

Authors:  Wayne Bond Lau; Ling Tao; Yajing Wang; Rong Li; Xin L Ma
Journal:  Antioxid Redox Signal       Date:  2011-04-20       Impact factor: 8.401

2.  Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms.

Authors:  Wei Yi; Yang Sun; Erhe Gao; Xufeng Wei; Wayne Bond Lau; Qijun Zheng; Yajing Wang; Yuexing Yuan; Xiaoliang Wang; Ling Tao; Rong Li; Walter Koch; Xin-Liang Ma
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

3.  Determinants of adiponectin levels in patients with chronic systolic heart failure.

Authors:  Andreia Biolo; Rei Shibata; Noriyuki Ouchi; Shinji Kihara; Mina Sonoda; Kenneth Walsh; Flora Sam
Journal:  Am J Cardiol       Date:  2010-02-20       Impact factor: 2.778

4.  Globular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses.

Authors:  Lina Zhao; Zhuo Fu; Jing Wu; Kevin W Aylor; Eugene J Barrett; Wenhong Cao; Zhenqi Liu
Journal:  J Physiol       Date:  2015-07-26       Impact factor: 5.182

Review 5.  Direct effects of adipokines on the heart: focus on adiponectin.

Authors:  Min Park; Gary Sweeney
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

Review 6.  Adiponectin and cardiovascular health: an update.

Authors:  Xiaoyan Hui; Karen S L Lam; Paul M Vanhoutte; Aimin Xu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 7.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

8.  Adiponectin and risk of vascular events in the Northern Manhattan study.

Authors:  Hannah Gardener; Ronald Goldberg; Armando J Mendez; Clinton B Wright; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Atherosclerosis       Date:  2012-11-28       Impact factor: 5.162

9.  What can adiponectin say about left ventricular function?

Authors:  Flora Sam; Kenneth Walsh
Journal:  Heart       Date:  2009-11-23       Impact factor: 5.994

10.  Chronic liquid nutrition intake induces obesity and considerable but reversible metabolic alterations in Wistar rats.

Authors:  Livia Mikuska; Michaela Vrabcova; Andrej Tillinger; Miroslav Balaz; Jozef Ukropec; Boris Mravec
Journal:  J Physiol Biochem       Date:  2016-03-03       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.